Insulinoma MRI: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Abdominal MRI is helpful in the diagnosis of | Abdominal MRI is helpful in the diagnosis of insulinoma. On abdominal MRI, insulinoma is characterized by a mass which is hypointense on T1-weighted MRI, hyperintense on T2-weighted MRI, and signal enhancement on T1 C+ (Gd).<ref name=MRI>Insulinoma. Dr Yuranga Weerakkody and Dr Frank Gaillard et al. http://radiopaedia.org/articles/insulinoma accessed on 10 October, 2015.</ref><ref name="pmid23430217">{{cite journal| author=Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y et al.| title=Diagnosis and management of insulinoma. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 6 | pages= 829-37 | pmid=23430217 | doi=10.3748/wjg.v19.i6.829 | pmc=PMC3574879 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23430217 }} </ref> | ||
==MRI== | ==MRI== | ||
Revision as of 17:11, 9 October 2015
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma MRI On the Web |
|
American Roentgen Ray Society Images of Insulinoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Abdominal MRI is helpful in the diagnosis of insulinoma. On abdominal MRI, insulinoma is characterized by a mass which is hypointense on T1-weighted MRI, hyperintense on T2-weighted MRI, and signal enhancement on T1 C+ (Gd).[1][2]
MRI
- T1 C+ (Gd): signal enhancement
- T1: low signal intensity
- T2: high signal intensity
References
- ↑ 1.0 1.1 Insulinoma. Dr Yuranga Weerakkody and Dr Frank Gaillard et al. http://radiopaedia.org/articles/insulinoma accessed on 10 October, 2015.
- ↑ 2.0 2.1 Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y; et al. (2013). "Diagnosis and management of insulinoma". World J Gastroenterol. 19 (6): 829–37. doi:10.3748/wjg.v19.i6.829. PMC 3574879. PMID 23430217.